Education
About Us
Working with TipRanks
Follow Us
180 Life Sciences (ATNF)
NASDAQ:ATNF
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -105.67K | $ -109.00K | $ -116.30K | $ -125.33K |
| Operating Income | $ -6.32M | $ -13.48M | $ -17.90M | $ -15.64M | $ -5.65M |
| EBITDA | $ -6.32M | $ -22.13M | $ -17.79M | $ -20.05M | $ -5.52M |
| Net Income | $ -6.17M | $ -19.94M | $ -38.73M | $ -20.32M | $ -12.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.59M | $ 1.98M | $ 6.97M | $ 8.22M | $ 2.11M |
| Total Assets | $ 12.76M | $ 5.26M | $ 19.65M | $ 62.71M | $ 55.53M |
| Total Debt | $ 154.50K | $ 1.05M | $ 1.34M | $ 1.96M | $ 3.78M |
| Net Debt | $ -4.43M | $ -921.74K | $ -5.63M | $ -6.27M | $ 1.67M |
| Total Liabilities | $ 3.51M | $ 5.39M | $ 8.31M | $ 23.39M | $ 25.25M |
| Stockholders' Equity | $ 9.25M | $ -127.73K | $ 11.34M | $ 39.32M | $ 30.29M |
| Cash Flow | |||||
| Free Cash Flow | $ -1.48M | $ -10.92M | $ -12.13M | $ -19.37M | $ -3.87M |
| Operating Cash Flow | $ -1.48M | $ -10.92M | $ -12.13M | $ -19.37M | $ -3.87M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 14.49M |
| Financing Cash Flow | $ 4.04M | $ 5.91M | $ 10.87M | $ 25.41M | $ -8.73M |
180 Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.